$WYY
WIDEPOINT CORP Stock $wyy

$wyy Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-Q Financial Statement

#000114420416132822 Filed on November 09, 2016

Income Statement

Concept	2016 Q4	2016 Q3	2015 Q4
Revenue	$18.26M	$22.11M	$18.71M
YoY Change	-2.43%	30.13%	11.64%
Cost Of Revenue	$15.85M	$18.08M	$15.48M
YoY Change	2.39%	30.26%	16.22%
Gross Profit	$2.410M	$4.038M	$3.237M
YoY Change	-25.55%	29.45%	-6.13%
Gross Profit Margin	13.2%	18.26%	17.3%
Selling, General & Admin	$4.400M	$4.076M	$5.050M
YoY Change	-12.87%	-12.49%	-12.17%
% of Gross Profit	182.57%	100.95%	156.0%
Research & Development	$440.0K	$2.648K	$670.0K
YoY Change	-34.33%	-99.02%
% of Gross Profit	18.26%	0.07%	20.7%
Depreciation & Amortization	$400.0K	$84.76K	$420.0K
YoY Change	-4.76%	-8.83%	-10.64%
% of Gross Profit	16.6%	2.1%	12.97%
Operating Expenses	$4.930M	$4.164M	$5.820M
YoY Change	-15.29%	-12.37%	1.39%
Operating Profit	-$2.520M	-$125.6K	-$1.334M
YoY Change	88.91%	-92.3%	28.99%
Interest Expense	-$10.00K	$20.91K	-$30.00K
YoY Change	-66.67%	-32.26%	-25.0%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$14.12K	$0.00
YoY Change		-77.1%	-100.0%
Pretax Income	-$2.520M	-$139.7K	-$1.360M
YoY Change	85.29%	-91.75%	27.1%
Income Tax	-$90.00K	$8.295K	-$230.0K
% Of Pretax Income
Net Earnings	-$2.430M	-$150.0K	-$1.136M
YoY Change	113.92%	-91.49%	25.8%
Net Earnings / Revenue	-13.31%	-0.68%	-6.07%
Basic Earnings Per Share			-$0.01
Diluted Earnings Per Share	-$29.37K	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	82.73M shares	82.73M shares
Diluted Shares Outstanding		82.73M shares

Balance Sheet

Concept	2016 Q4	2016 Q3	2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.120M	$5.590M	$7.930M
YoY Change	15.01%	-46.46%	-39.7%
Cash & Equivalents	$9.123M	$5.586M	$7.930M
Short-Term Investments
Other Short-Term Assets	$551.6K	$440.0K	$470.0K
YoY Change	17.36%	4.76%	4.44%
Inventory	$123.3K	$370.0K	$28.40K
Prepaid Expenses
Receivables	$5.153M	$18.38M	$10.57M
Other Receivables	$40.00K	$0.00	$0.00
Total Short-Term Assets	$22.94M	$24.78M	$25.63M
YoY Change	-10.49%	-8.04%	-7.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$740.0K	$1.322M	$1.513M
YoY Change	-51.1%	-14.17%	-6.25%
Goodwill	$18.56M	$18.56M	$18.56M
YoY Change	0.0%		0.0%
Intangibles	$4.299M	$4.761M	$5.102M
YoY Change	-15.73%		-14.88%
Long-Term Investments
YoY Change
Other Assets	$52.46K	$53.96K	$60.47K
YoY Change	-13.25%	-60.49%	-62.67%
Total Long-Term Assets	$24.24M	$24.69M	$25.23M
YoY Change	-3.93%	-3.65%	-4.16%
TOTAL ASSETS
Total Short-Term Assets	$22.94M	$24.78M	$25.63M
Total Long-Term Assets	$24.24M	$24.69M	$25.23M
Total Assets	$47.18M	$49.48M	$50.86M
YoY Change	-7.24%	-5.9%	-5.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.708M	$9.027M	$7.812M
YoY Change	11.47%	39.98%	26.71%
Accrued Expenses	$7.835M	$7.100M	$6.687M
YoY Change	17.16%	9.39%	11.82%
Deferred Revenue
YoY Change
Short-Term Debt	$130.0K	$170.0K	$130.0K
YoY Change	0.0%	-91.75%	-7.14%
Long-Term Debt Due	$94.87K	$242.5K	$893.7K
YoY Change	-89.38%	-72.41%	-59.08%
Total Short-Term Liabilities	$18.00M	$17.79M	$17.63M
YoY Change	2.14%	-1.05%	15.4%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$417.2K	$431.8K
YoY Change	-100.0%	-37.1%	-67.48%
Other Long-Term Liabilities	$90.00K	$140.0K	$150.0K
YoY Change	-40.0%	-30.0%	-28.57%
Total Long-Term Liabilities	$0.00	$417.2K	$431.8K
YoY Change	-100.0%	-37.1%	-67.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.00M	$17.79M	$17.63M
Total Long-Term Liabilities	$0.00	$417.2K	$431.8K
Total Liabilities	$18.90M	$18.79M	$18.67M
YoY Change	1.26%	-2.62%	7.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$65.42M	-$62.99M	-$61.28M
YoY Change	6.75%	4.72%	9.79%
Common Stock	$94.00M	$93.90M	$93.74M
YoY Change	0.28%	113684.67%	1.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.28M	$30.69M	$32.19M
YoY Change
Total Liabilities & Shareholders Equity	$47.18M	$49.48M	$50.86M
YoY Change	-7.24%	-5.9%	-5.95%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2015 Q4
OPERATING ACTIVITIES
Net Income	-$2.430M	-$150.0K	-$1.136M
YoY Change	113.92%	-91.49%	25.8%
Depreciation, Depletion And Amortization	$400.0K	$84.76K	$420.0K
YoY Change	-4.76%	-8.83%	-10.64%
Cash From Operating Activities	$3.920M	-$2.190M	-$70.00K
YoY Change	-5700.0%	151.72%	-450.0%
INVESTING ACTIVITIES
Capital Expenditures	$20.00K	-$330.0K	-$100.0K
YoY Change	-120.0%	175.0%	150.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00		$0.00
YoY Change			-100.0%
Cash From Investing Activities	$20.00K	-$330.0K	-$100.0K
YoY Change	-120.0%	175.0%	-1100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-280.0K	-240.0K	-2.250M
YoY Change	-87.56%	-114.2%	-122.15%
NET CHANGE
Cash From Operating Activities	3.920M	-2.190M	-70.00K
Cash From Investing Activities	20.00K	-330.0K	-100.0K
Cash From Financing Activities	-280.0K	-240.0K	-2.250M
Net Change In Cash	3.660M	-2.760M	-2.420M
YoY Change	-251.24%	-494.29%	-123.75%
FREE CASH FLOW
Cash From Operating Activities	$3.920M	-$2.190M	-$70.00K
Capital Expenditures	$20.00K	-$330.0K	-$100.0K
Free Cash Flow	$3.900M	-$1.860M	$30.00K
YoY Change	12900.0%	148.0%	-50.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	309024	USD
CY2016Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50858471	USD
CY2016Q3	us-gaap	Common Stock Value CommonStockValue	82730	USD
CY2015Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	21940	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	342292	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	695494	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	480355	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	186354	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	8728	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	32332	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2016Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	12115482	USD
CY2015Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	10638491	USD
CY2016Q3	wyy	Unbilled Accounts Receivable UnbilledAccountsReceivable	6344989	USD
CY2015Q4	wyy	Unbilled Accounts Receivable UnbilledAccountsReceivable	6637587	USD
CY2016Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4642020	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4495369	USD
CY2016Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3320257	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2982062	USD
CY2015Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	372600	USD
CY2016Q3	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	286800	USD
	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P5Y9M18D
CY2015Q3	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	272700	USD
CY2016Q3	us-gaap	Long Term Debt LongTermDebt	659758	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	1325462	USD
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	110000000	shares
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82730134	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	209438	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-863933	shares
CY2016Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	6578049	shares
CY2016Q3	us-gaap	Assets Current AssetsCurrent	24782732	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	25627592	USD
CY2016Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1321763	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1513307	USD
CY2016Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4761199	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5101523	USD
CY2016Q3	us-gaap	Goodwill Goodwill	18555578	USD
CY2015Q4	us-gaap	Goodwill Goodwill	18555578	USD
CY2016Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53956	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	60471	USD
CY2016Q3	us-gaap	Assets Assets	49475228	USD
CY2015Q4	us-gaap	Assets Assets	50858471	USD
CY2016Q3	us-gaap	Notes Payable Current NotesPayableCurrent	48787	USD
CY2015Q4	us-gaap	Notes Payable Current NotesPayableCurrent	131953	USD
CY2016Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	9026925	USD
CY2016Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	48663	USD
CY2015Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	37684	USD
CY2016Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	242536	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	893706	USD
CY2016Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	10030	USD
CY2015Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	28752	USD
CY2016Q3	us-gaap	Liabilities Current LiabilitiesCurrent	17787091	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17599345	USD
CY2016Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	417222	USD
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	431756	USD
CY2016Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	0	USD
CY2015Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	11962	USD
CY2016Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	137851	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	151994	USD
CY2016Q3	us-gaap	Deferred Revenue DeferredRevenue	0	USD
CY2015Q4	us-gaap	Deferred Revenue DeferredRevenue	24937	USD
CY2016Q3	us-gaap	Liabilities Liabilities	18789975	USD
CY2015Q4	us-gaap	Liabilities Liabilities	18667805	USD
CY2016Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	93813519	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	93661178	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-223623	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-270140	USD
CY2016Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62987373	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	447811	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61282893	USD
CY2016Q3	us-gaap	Stockholders Equity StockholdersEquity	30685253	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11027431	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	32190666	USD
CY2016Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	49475228	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10650697	USD
CY2016Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	44019	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	268956	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	30889	USD
CY2016Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	447811	USD
	us-gaap	Operating Expenses OperatingExpenses	13247679	USD
CY2016Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	126007	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1644125	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-55503	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	52123171	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	60163145	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4183480	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	147187	USD
	us-gaap	Gross Profit GrossProfit	11603554	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2333039	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4330667	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2066995	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	283211	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82130665	shares
	us-gaap	Operating Expenses OperatingExpenses	14123559	USD
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82130665	shares
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4127977	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	10618	USD
	us-gaap	Interest Expense InterestExpense	61068	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	37826	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11124	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-39326	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1683451	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21029	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1704480	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82673570	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82673570	shares
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	261031	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	479878	USD
	wyy	Cost Of Sales Gross CostOfSalesGross	48559591	USD
	wyy	Cost Of Sales Gross CostOfSalesGross	42127589	USD
	us-gaap	Gross Profit GrossProfit	9995582	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	17924	USD
	us-gaap	Interest Expense InterestExpense	111253	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-74997	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	21940	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	46517	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2648	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	268853	USD
CY2016Q3	wyy	Cost Of Sales Gross CostOfSalesGross	18076810	USD
CY2015Q3	wyy	Cost Of Sales Gross CostOfSalesGross	13875473	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-132674	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	46517	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-74997	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4405664	USD
CY2016Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	15366	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	15366	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1741340	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12213	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2894	USD
	us-gaap	Depreciation Depreciation	336147	USD
	us-gaap	Depreciation Depreciation	353387	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-7932	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	36783	USD
	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	820679	USD
	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	803548	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	204414	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	208091	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-9716	USD
	wyy	Increase Decrease In Accounts Receivable And Unbilled Accounts Receivable IncreaseDecreaseInAccountsReceivableAndUnbilledAccountsReceivable	946390	USD
	wyy	Increase Decrease In Accounts Receivable And Unbilled Accounts Receivable IncreaseDecreaseInAccountsReceivableAndUnbilledAccountsReceivable	1807139	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10443065	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10362	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-19293	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6241	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-6515	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-14747	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1309782	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	509939	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-11183	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	78705	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-880982	USD
	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	1269533	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1208642	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2825132	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-625601	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-495378	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	18254362	USD
	wyy	Principal Repayments Of Bank Line Of Credit PrincipalRepaymentsOfBankLineOfCredit	18128355	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	665704	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	26396	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	701706	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-598425	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	87924	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-86618	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2344744	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2711634	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13154699	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	145246	USD
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.91
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y7M6D
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
	wyy	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Weighted Average Remaining Contractual Term1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerm1	P2Y7M6D
CY2016Q3	wyy	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding And Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingAndExercisableAggregateIntrinsicValue	0	USD
CY2016Q3	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	307235	USD
CY2015Q3	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	290011	USD
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	873724	USD
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3402211	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1857668	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M24D
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	82130665	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2791601	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	650000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	180000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2115668	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1857668	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1989739	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1857668	shares
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1183168	shares
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1003496	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.91
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.83
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.7
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.45
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.62
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.74
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.81
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.87
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.88
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.91
CY2016Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.82
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.67
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	841672	shares
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	1340838	shares
CY2016Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	932500	shares
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	854172	shares
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.8
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.57
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.4
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.7
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.69
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.27
CY2016Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.59
CY2015Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.8
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.72
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.39
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2115668	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1857668	shares
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2016-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	WIDEPOINT CORP
	dei	Entity Central Index Key EntityCentralIndexKey	0001034760
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Accelerated Filer
	dei	Trading Symbol TradingSymbol	WYY
CY2016Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82730134	shares
CY2016Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	76235	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	73378	USD
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2045714	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2045714	shares
CY2016Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	110000000	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82730134	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	82520696	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82520696	shares
	us-gaap	Interest Paid Net InterestPaidNet	58125	USD
	us-gaap	Interest Paid Net InterestPaidNet	128118	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	4031	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	11042	USD
	us-gaap	Notes Issued1 NotesIssued1	62352	USD
	us-gaap	Notes Issued1 NotesIssued1	0	USD
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Reclassifications</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px 0pt 0.05in; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company reclassified amounts representing product development previously included in the caption “general and administrative expenses” in the comparative statement of operations presentation as a separate line item to conform to the current year presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Use of Estimates</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.3in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The more significant areas requiring use of estimates and judgment relate to revenue recognition, accounts receivable valuation reserves, ability to realize intangible assets and goodwill, ability to realize deferred income tax assets, fair value of certain financial instruments and the evaluation of contingencies and litigation. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	309100	USD
CY2015Q4	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	21200	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	309100	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2115668	shares
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1857668	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	416666	shares
CY2016Q2	wyy	Debt Instrument Covenant Terms Current Ratio DebtInstrumentCovenantTermsCurrentRatio	1.1:1
	wyy	Minimum After Tax Net Income Requirement MinimumAfterTaxNetIncomeRequirement	1.00	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	32300	USD
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	887870	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	68088	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	89229	USD
CY2016Q3	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	63500	USD
CY2016Q3	us-gaap	Capital Leases Balance Sheet Assets By Major Class Net CapitalLeasesBalanceSheetAssetsByMajorClassNet	30100	USD
CY2016Q3	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	246900	USD
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	480300	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	25000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	537142	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	250000	shares

Files In Submission

Name	View Source	Status
0001144204-16-132822-index-headers.html	Edgar Link	pending
0001144204-16-132822-index.html	Edgar Link	pending
0001144204-16-132822.txt	Edgar Link	pending
0001144204-16-132822-xbrl.zip	Edgar Link	pending
ex102_001.jpg	Edgar Link	pending
ex102_002.jpg	Edgar Link	pending
ex102_003.jpg	Edgar Link	pending
ex102_004.jpg	Edgar Link	pending
ex102_005.jpg	Edgar Link	pending
ex102_006.jpg	Edgar Link	pending
ex102_007.jpg	Edgar Link	pending
ex102_008.jpg	Edgar Link	pending
ex102_009.jpg	Edgar Link	pending
ex102_010.jpg	Edgar Link	pending
ex102_011.jpg	Edgar Link	pending
ex102_012.jpg	Edgar Link	pending
ex102_013.jpg	Edgar Link	pending
ex102_014.jpg	Edgar Link	pending
ex102_015.jpg	Edgar Link	pending
ex102_016.jpg	Edgar Link	pending
ex102_017.jpg	Edgar Link	pending
ex102_018.jpg	Edgar Link	pending
ex102_019.jpg	Edgar Link	pending
ex102_020.jpg	Edgar Link	pending
ex102_021.jpg	Edgar Link	pending
ex102_022.jpg	Edgar Link	pending
ex102_023.jpg	Edgar Link	pending
ex102_024.jpg	Edgar Link	pending
ex102_025.jpg	Edgar Link	pending
ex102_026.jpg	Edgar Link	pending
ex102_027.jpg	Edgar Link	pending
ex102_028.jpg	Edgar Link	pending
ex102_029.jpg	Edgar Link	pending
ex102_030.jpg	Edgar Link	pending
ex102_031.jpg	Edgar Link	pending
ex102_032.jpg	Edgar Link	pending
ex102_033.jpg	Edgar Link	pending
ex102_034.jpg	Edgar Link	pending
ex102_035.jpg	Edgar Link	pending
ex10x1_001.jpg	Edgar Link	pending
ex10x1_002.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v451320_10q.htm	Edgar Link	pending
v451320_ex10-1.htm	Edgar Link	pending
v451320_ex10-2.htm	Edgar Link	pending
v451320_ex31-1.htm	Edgar Link	pending
v451320_ex31-2.htm	Edgar Link	pending
v451320_ex32.htm	Edgar Link	pending
wyy-20160930.xml	Edgar Link	completed
wyy-20160930.xsd	Edgar Link	pending
wyy-20160930_cal.xml	Edgar Link	unprocessable
wyy-20160930_def.xml	Edgar Link	unprocessable
wyy-20160930_lab.xml	Edgar Link	unprocessable
wyy-20160930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WYY
WIDEPOINT CORP Stock $wyy

2016 Q4 Form 10-Q Financial Statement

#000114420416132822 Filed on November 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WYY WIDEPOINT CORP Stock $wyy

2016 Q4 Form 10-Q Financial Statement

#000114420416132822 Filed on November 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WYY
WIDEPOINT CORP Stock $wyy